Stay updated with breaking news from Nuclear Export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year target […]
Monashee Investment Management LLC purchased a new position in shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 481,696 shares of the company’s stock, valued at approximately $1,638,000. Other hedge funds and other institutional investors have also recently added […]
Karyopharm Therapeutics (NASDAQ:KPTI – Get Rating) had its target price lowered by Robert W. Baird from $14.00 to $10.00 in a research report sent to investors on Friday, The Fly reports. A number of other research analysts have also issued reports on KPTI. HC Wainwright lowered their target price on Karyopharm Therapeutics from $16.00 to […]
Karyopharm Therapeutics (NASDAQ:KPTI – Get Rating) had its price objective cut by HC Wainwright from $16.00 to $10.00 in a research note released on Friday, The Fly reports. Other research analysts also recently issued reports about the stock. Morgan Stanley lowered their price target on shares of Karyopharm Therapeutics from $7.00 to $5.00 and set […]
Karyopharm Therapeutics (NASDAQ:KPTI – Get Rating) had its price target lowered by HC Wainwright from $16.00 to $10.00 in a research note released on Friday, The Fly reports. A number of other analysts have also recently issued reports on the company. Morgan Stanley dropped their price objective on Karyopharm Therapeutics from $7.00 to $5.00 and […]